top of page

A20 Syngeneic Model

Rincon Bio offers efficacy studies using the A20 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Syngeneic
Organ:
Blood
ATCC link (if available):
Derivation:
Spontaneous tumor in a BALB/c AnN mouse
Mutations:
Unavailable
NCI60:
Yes
Weeks from stratification to termination (average):
N/A

A20 Growth Curve

(Representative of studies performed at Rincon Bio)

Contact Rincon Bio for a growth curve and more information on the A20 syngeneic model.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page